Despite recent advances in the prevention and treatment of cardiovascular disease, the prevalence of heart failure, a worldwide health threat, continues to grow. Current therapeutic strategies for heart failure are largely directed at disturbances in the neurohormonal axis rather than targeting the myocyte. Evidence is emerging that alterations in myocyte energy metabolism contributes to the pathogenesis of heart failure. Previous work linked to this RO1-funded project has shown that a gene regulatory cascade, under the influence of the transcriptional coactivators, PPAR3 transcriptional coactivator-11 and 2 (PGC-11 and PGC-12), controls the expression of genes involved in a wide array of mitochondrial energy transduction and ATP-generating processes in the cardiac myocyte. The results of our recent studies conducted in mice deficient for the PGC-1 coactivators have shown that the PGC-1 regulatory cascade is required for postnatal mitochondrial biogenic maturation. We have also found that the expression and activity of the PGC-1 coactivators are downregulated in pathologic forms of cardiac hypertrophy and in the failing heart. These findings have led to the central hypothesis of this renewal proposal that chronic deactivation of PGC-1 signaling in the adult heart contributes to the progressive pathologic metabolic and functional remodeling that leads to end-stage heart failure. To test this hypothesis we will: (1) conduct mitochondrial functional and proteomic studies in the hearts of adult mice in which the cardiac PGC-1 gene regulatory cascade has been deactivated;(2) define mitochondrial functional and proteomic derangements in hearts of wild-type mice subjected to pressure overload and ischemic insult and compare the results with the dataset generated in the PGC-1-deficient hearts in order to identify shared signatures;(3) explore the potential role of PGC-1 coactivators in the control of mitochondrial dynamics (fusion, fission, biogenesis);and (4) devise and implement proof-of-concept "rescue" studies in which PGC-1 coactivators or relevant downstream targets are reactivated in heart failure models in wild-type mice. In the long-term, we seek to identify and validate novel targets aimed at modulating cardiac metabolism as a novel approach to prevent or treat heart failure in its early stages. )

Public Health Relevance

Heart failure is a growing worldwide health threat. This project seeks to understand how changes in the metabolism of the heart contribute to the development of heart failure. This work should identify new approaches to treat heart failure by boosting its energy supply.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL058493-15
Application #
8288236
Study Section
Myocardial Ischemia and Metabolism Study Section (MIM)
Program Officer
Wong, Renee P
Project Start
1998-04-01
Project End
2015-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
15
Fiscal Year
2012
Total Cost
$472,725
Indirect Cost
$225,225
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
020520466
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Theodosakis, Nicholas; Micevic, Goran; Kelly, Daniel P et al. (2014) Mitochondrial function in melanoma. Arch Biochem Biophys 563:56-9
Din, Shabana; Konstandin, Mathias H; Johnson, Bevan et al. (2014) Metabolic dysfunction consistent with premature aging results from deletion of Pim kinases. Circ Res 115:376-87
Lai, Ling; Leone, Teresa C; Keller, Mark P et al. (2014) Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach. Circ Heart Fail 7:1022-31
Martin, Ola J; Lai, Ling; Soundarapandian, Mangala M et al. (2014) A role for peroxisome proliferator-activated receptor ýý coactivator-1 in the control of mitochondrial dynamics during postnatal cardiac growth. Circ Res 114:626-36
Lai, Ling; Wang, Miao; Martin, Ola J et al. (2014) A role for peroxisome proliferator-activated receptor ýý coactivator 1 (PGC-1) in the regulation of cardiac mitochondrial phospholipid biosynthesis. J Biol Chem 289:2250-9
Valtat, Berengere; Riveline, Jean-Pierre; Zhang, Ping et al. (2013) Fetal PGC-1ýý overexpression programs adult pancreatic ýý-cell dysfunction. Diabetes 62:1206-16
Kim, Changsung; Wong, Johnson; Wen, Jianyan et al. (2013) Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature 494:105-10
Shi, Jianru; Jiang, Bingbing; Qiu, Yiling et al. (2013) PGC1* plays a critical role in TWEAK-induced cardiac dysfunction. PLoS One 8:e54054
Aubert, Gregory; Vega, Rick B; Kelly, Daniel P (2013) Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart. Biochim Biophys Acta 1833:840-7
Mitra, Riddhi; Nogee, Daniel P; Zechner, Juliet F et al. (2012) The transcriptional coactivators, PGC-1* and *, cooperate to maintain cardiac mitochondrial function during the early stages of insulin resistance. J Mol Cell Cardiol 52:701-10

Showing the most recent 10 out of 44 publications